Type I interferonopathies—an expanding disease spectrum of immunodysregulation
- 22 May 2015
- journal article
- review article
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 37 (4) , 349-357
Abstract
Type I interferons (IFNs) play a central role in the immune defense against viral infections. Type I IFN signaling is activated by pattern recognition receptors upon sensing of viral nucleic acids and induces antiviral programs through modulation of innate and adaptive immune responses. Type I interferonopathies comprise a heterogenous group of genetically determined diseases that are characterized by inappropriate activation of type I IFN. While their phenotypic spectrum is broad, ranging from severe neurological impairment to mild cutaneous disease, systemic autoinflammation, and autoimmunity are commonly shared signs of type I interferonopathies. Although the mechanisms underlying various disease phenotypes associated with inappropriate type I IFN activation have yet to be fully elucidated, our current understanding of the molecular pathogenesis of type I interferonopathies has provided a set of candidate molecules that can be interrogated in search of targeted therapies.Keywords
This publication has 78 references indexed in Scilit:
- Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphatesNature, 2014
- The history of Toll-like receptors — redefining innate immunityNature Reviews Immunology, 2013
- Molecular Basis of DNA Recognition in the Immune SystemThe Journal of Immunology, 2013
- RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I PathwayCell, 2009
- RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III–transcribed RNA intermediateNature Immunology, 2009
- 5'-Triphosphate RNA Is the Ligand for RIG-IScience, 2006
- Toll-like receptors in systemic autoimmune diseaseNature Reviews Immunology, 2006
- Type I Interferons in Host DefenseImmunity, 2006
- IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon inductionNature Immunology, 2005
- A weak signal for strong responses: interferon-alpha/beta revisitedNature Reviews Molecular Cell Biology, 2001